TYRA (STOCKS)
Tyra Biosciences, Inc. Common Stock
$30.000000
-1.400000 (-4.46%)
Prev close: $31.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Todd J. Harris
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,619.66M
- Employees
- 60
- P/E (TTM)
- -16.70
- P/B (TTM)
- 5.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $14.31M |
| Operating Expenses | $125.99M |
| Research and Development | $96.92M |
| Other Operating Expenses | $29.07M |
| Operating Income/Loss | -$125.99M |
| Income/Loss From Continuing Operations After Tax | -$111.68M |
| Income/Loss From Continuing Operations Before Tax | -$111.68M |
| Net Income/Loss | -$111.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$111.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$111.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.87 |
| Diluted Earnings Per Share | -$1.87 |
| Basic Average Shares | 60,142,673 |
| Diluted Average Shares | 179,176,774 |
| Assets | $301.85M |
| Current Assets | $281.22M |
| Noncurrent Assets | $20.64M |
| Fixed Assets | $1.35M |
| Other Non-current Assets | $19.29M |
| Liabilities | $21.34M |
| Current Liabilities | $15.88M |
| Accounts Payable | $1.99M |
| Other Current Liabilities | $13.89M |
| Noncurrent Liabilities | $5.46M |
| Equity | $280.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $280.51M |
| Liabilities And Equity | $301.85M |
| Net Cash Flow From Operating Activities | -$91.11M |
| Net Cash Flow From Operating Activities, Continuing | -$91.11M |
| Net Cash Flow From Investing Activities | $45.04M |
| Net Cash Flow From Investing Activities, Continuing | $45.04M |
| Net Cash Flow From Financing Activities | $4.12M |
| Net Cash Flow From Financing Activities, Continuing | $4.12M |
| Net Cash Flow | -$41.94M |
| Net Cash Flow, Continuing | -$41.94M |
| Comprehensive Income/Loss | -$112.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$112.99M |
| Other Comprehensive Income/Loss | -$56.42M |